SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?


To: Andreas Helke who wrote (2)5/8/1998 1:50:00 PM
From: Larry Liebman  Read Replies (2) | Respond to of 222
 
Andreas. I took a small position at 6 1/4 today. Gillis helped develop IMNX into one of the premiere R&D biotechs. With cash at $4.75/sh and the stock at 6 1/4 it meets my criteria for significant risk/reward returns. I also read the Lehman report which holds that additional pharma collaborations are in the offing.